Overview
X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome, also known as MHIO syndrome or Zunich neuroectodermal syndrome (though sometimes referenced under different eponyms), is an extremely rare X-linked genetic condition characterized by a distinctive combination of features affecting multiple body systems. The syndrome was originally described in a small number of affected males and is defined by the co-occurrence of intellectual disability of variable severity, hypogonadism (underdevelopment of the reproductive system with reduced gonadal function), ichthyosis (a skin disorder characterized by dry, thickened, scaly skin), obesity, and short stature. Additional features may include gynecomastia and characteristic facial features. The neurological system is primarily affected through cognitive impairment, while the endocrine system is involved through hypogonadotropic or hypergonadotropic hypogonadism, and the integumentary system is affected by ichthyosis. Because of its extreme rarity, the molecular genetic basis of this syndrome has not been fully elucidated in all reported cases, and diagnosis is primarily clinical, based on the recognition of the characteristic pattern of features. Management is supportive and symptomatic, involving educational support and developmental interventions for intellectual disability, dermatological care including emollients and keratolytics for ichthyosis, endocrine evaluation and possible hormone replacement therapy for hypogonadism, and monitoring of weight and metabolic parameters related to obesity. Growth hormone evaluation may be considered for short stature. Genetic counseling is recommended for affected families given the X-linked pattern of inheritance. No curative treatment currently exists for this condition.
Also known as:
Clinical phenotype terms— hover any for plain English:
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome.
Community
No community posts yet. Be the first to share your experience with X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome.
Start the conversation →Latest news about X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome
No recent news articles for X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome
What is X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome?
X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome, also known as MHIO syndrome or Zunich neuroectodermal syndrome (though sometimes referenced under different eponyms), is an extremely rare X-linked genetic condition characterized by a distinctive combination of features affecting multiple body systems. The syndrome was originally described in a small number of affected males and is defined by the co-occurrence of intellectual disability of variable severity, hypogonadism (underdevelopment of the reproductive system with reduced gonadal function), ichthyos
How is X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome inherited?
X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome typically begin?
Typical onset of X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome is childhood. Age of onset can vary across affected individuals.